annual cash & cash equivalents:
$41.67M-$44.43M(-51.61%)Summary
- As of today (July 6, 2025), EWTX annual cash & cash equivalents is $41.67 million, with the most recent change of -$44.43 million (-51.61%) on December 31, 2024.
- During the last 3 years, EWTX annual cash & cash equivalents has risen by +$26.10 million (+167.67%).
- EWTX annual cash & cash equivalents is now -60.29% below its all-time high of $104.92 million, reached on December 31, 2020.
Performance
EWTX Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$49.92M+$8.26M(+19.81%)Summary
- As of today (July 6, 2025), EWTX quarterly cash & cash equivalents is $49.92 million, with the most recent change of +$8.26 million (+19.81%) on March 31, 2025.
- Over the past year, EWTX quarterly cash & cash equivalents has increased by +$19.66 million (+64.95%).
- EWTX quarterly cash & cash equivalents is now -77.41% below its all-time high of $221.04 million, reached on March 31, 2021.
Performance
EWTX quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
EWTX Cash and cash equivalents Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -51.6% | +65.0% |
3 y3 years | +167.7% | +44.9% |
5 y5 years | +76.2% | - |
EWTX Cash and cash equivalents Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -51.6% | +167.7% | -54.5% | +172.2% |
5 y | 5-year | -60.3% | +167.7% | -77.4% | +372.2% |
alltime | all time | -60.3% | +167.7% | -77.4% | +372.2% |
EWTX Cash and cash equivalents History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $49.92M(+19.8%) |
Dec 2024 | $41.67M(-51.6%) | $41.67M(-7.0%) |
Sep 2024 | - | $44.81M(+3.0%) |
Jun 2024 | - | $43.48M(+43.7%) |
Mar 2024 | - | $30.26M(-64.8%) |
Dec 2023 | $86.10M(+291.5%) | $86.10M(+161.2%) |
Sep 2023 | - | $32.96M(+3.6%) |
Jun 2023 | - | $31.81M(-34.1%) |
Mar 2023 | - | $48.23M(+119.3%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2022 | $21.99M(+41.3%) | $21.99M(-80.0%) |
Sep 2022 | - | $109.75M(+498.4%) |
Jun 2022 | - | $18.34M(-46.8%) |
Mar 2022 | - | $34.45M(+121.3%) |
Dec 2021 | $15.57M(-85.2%) | $15.57M(+47.3%) |
Sep 2021 | - | $10.57M(-79.0%) |
Jun 2021 | - | $50.40M(-77.2%) |
Mar 2021 | - | $221.04M(+110.7%) |
Dec 2020 | $104.92M(+343.6%) | $104.92M |
Dec 2019 | $23.65M | - |
FAQ
- What is Edgewise Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Edgewise Therapeutics?
- What is Edgewise Therapeutics annual cash & cash equivalents year-on-year change?
- What is Edgewise Therapeutics quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Edgewise Therapeutics?
- What is Edgewise Therapeutics quarterly cash & cash equivalents year-on-year change?
What is Edgewise Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of EWTX is $41.67M
What is the all time high annual cash & cash equivalents for Edgewise Therapeutics?
Edgewise Therapeutics all-time high annual cash & cash equivalents is $104.92M
What is Edgewise Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, EWTX annual cash & cash equivalents has changed by -$44.43M (-51.61%)
What is Edgewise Therapeutics quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of EWTX is $49.92M
What is the all time high quarterly cash & cash equivalents for Edgewise Therapeutics?
Edgewise Therapeutics all-time high quarterly cash & cash equivalents is $221.04M
What is Edgewise Therapeutics quarterly cash & cash equivalents year-on-year change?
Over the past year, EWTX quarterly cash & cash equivalents has changed by +$19.66M (+64.95%)